ADRB2 and hydrops fetalis: Chronic stimulation of β-adrenergic receptors (βARs) induces adverse cardiac remodeling via Gαs protein-dependent pathways such as protein kinase A (PKA) signaling [1–5], which is a therapeutic basis for βAR antagonists (β-blockers) in heart failure (HF) [6–8].